With the advancement of science and technology, researchers have started exploring peptides as potential therapeutic agents. Peptides offer unique advantages over small molecules and biologics, making them attractive candidates for drug development. They possess high specificity and affinity for their target receptors, ensuring precise biological interactions. Additionally, peptides are often well-tolerated, as they are similar in structure to naturally occurring molecules in the body.

Peptide-based drugs, such as insulin and glucagon-like peptide-1 analogs used in the treatment of diabetes, have already been successfully developed and commercialized. These peptides function as APIs, as they are the active components responsible for the desired therapeutic effects. They are carefully synthesized, purified, and formulated into pharmaceutical dosage forms before reaching the patients.

In recent years, the field of peptide therapeutics has witnessed remarkable progress. Peptides have shown promise in various disease areas, including cancer, cardiovascular disorders, metabolic diseases, and central nervous system disorders. Peptides can act as agonists or antagonists, binding to specific receptors and modulating biological functions. They can also inhibit protein-protein interactions, disrupt cellular processes, or even stimulate immune responses.

One significant advantage of peptides in drug discovery is the ability to design and engineer them for specific purposes. By modifying the amino acid sequence, introducing chemical modifications, or incorporating non-natural amino acids, researchers can tune the peptide''s properties and fine-tune its therapeutic potential.